As already mentioned, our therapy is suitable for ALL types of tumours. In the course of our many years of experience, however, special cases have emerged, which we consider separately – including the treatment of prostate carcinoma.
The spectrum of conventional therapeutic measures commonly used to treat prostate carcinoma ranges from a simple hormone blockade up to total prostatectomy, chemotherapy and radiation or combinations of these. If metastases (secondary tumours) already exist, bone-forming agents such as pamidronic acid may sometimes be administered.
Despite the fact that these interventions can have significant side effects, the physician is often at a loss regarding how to proceed with treatment, such as when “hormone numbness” sets in or when chemotherapy is no longer effective.
This contrasts with many patients’ urgent desire for a gentle therapy to maintain continence and potency and avoid chemotherapy. This desire can however only be satisfied with a clear conscience if a sufficiently effective procedure is available for the respective case. The immune system must also be strategically boosted in case of prostate carcinoma, i.e. heat treatment of the prostate alone is not enough!
The combined use of regional deep hyperthermia, prostate shortwave hyperthermia and whole body hyperthermia, complemented by high-dose mistletoe infusion therapy is a worldwide innovation in the complementary treatment of prostate cancer.
Our treatment concept for prostate cancer, just as when treating other tumours, is based on an intensive biological cancer therapy (combination therapy). The goal is on the one hand to strengthen the immune system, while on the other hand weakening or killing off the tumour cells, metastases and above all the micro-metastases.
The therapy generally starts with a longer 1st treatment phase of up to 5 weeks and 4 to 5 hours per day (Monday to Friday, weekends remain free of treatment). After the 1st phase is completed, repeat treatments of shorter duration should take place after a certain period of time, depending on the result of conventional medicine checks and the condition of the patient.
Micro-metastasis can already occur at the beginning stages of tumour growth. That is why the concept of holistic cancer treatment must also include a response to any existing micro-metastases by means of whole-body hyperthermia. In the best-case scenario, this treatment should be regarded as prophylactic. But is medical action regarding cancer ever truly prophylactic and not merely reactive?
Alongside the direct effect on tumour development in the prostate through prostate hyperthermia, the inclusion of local deep hyperthermia – here the heating plate is placed in suprasymphysary location (above the pubic bone) – can help reach the area surrounding the organ. Doing so exposes not only the prostate but also the adjacent lymph node areas to the heat spectrum. As choline PET-CT follow-ups show, even large retroperitoneal (located behind the peritoneum) lymph nodes can be considerably reduced in size or almost eradicated using short-wave hyperthermia, for example. These large areas of prostate carcinoma tumour infestation would be untreatable using conventional irradiation, that is, these patients would be doomed to die. The fact that there may be good chances of recovery in such cases thanks to complementary therapy is still completely unknown. We have repeatedly observed such lymph node regression (choline PET CT). This clearly shows that so-called complementary medicine is no longer merely complementary but can also be highly autonomous and even indispensable. These possibilities should not be withheld from seriously ill patients with prostate carcinoma – or from other patients with cancerous tumours.
This method tackles local carcinoma growth in the prostate. The method was explained in detail in FORUM KOMPLEMENTÄRE ONKOLOGIE 2/99 (you can find the article in Dr. Maar’s blog). It must be emphasised that the usual microwave method is not suitable for the treatment the carcinoma. The shortwave principle ensures deeper penetration of the electric field. An attempt is made to also inhibit the growth of cells that are becoming malignant (“interface tissue”). Many positive experiences were made within one year using this procedure.
A heat probe is positioned in the prostate via a treatment catheter. Via an external device, the heat in the probe is gradually raised to around 48° to 52° and permanently monitored. The treatment takes about 1.5 hours. The therapy is repeated after two days. A third treatment is carried out after 3 weeks. After that, a follow-up examination is carried out by means of an MRI repetition. The local prostate shortwave therapy may also have to be repeated several times. The intervals are dependent on the course of the disease as well as the MRI results.
The hyperthermia procedures referred to are applied in alternation over an extended period of time and are embedded in daily mistletoe infusions. After testing whether the mistletoe is even tolerated (8 of 1000 patients treated thus far showed strong intolerance), the dose is quickly increased. Achieving tumour cells apoptosis (tumour cell death) requires intravenous high-dose therapy.